Dorzolamide x apraclonidine in the prevention of the intraocular pressure spike after Nd:YAG laser posterior capsulotomy

Current Eye Research

Volumn 25, Issue 4, 2002, Pages 237-241

  Arieta, Carlos E L ^a,b   Amaral, Marcela S ^a   Matuda, Eliana ^a   Crosta, Cybele ^a   De Carvalho Moreira Filho, Djalma ^a   José, Newton Kara ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APRACLONIDINE; DORZOLAMIDE;

ADULT; AGED; ARTICLE; CAPSULOTOMY; CATARACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; MAJOR CLINICAL STUDY; MALE; NEODYMIUM LASER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL ACUITY;

ADRENERGIC ALPHA-AGONISTS; ADULT; AGED; AGED, 80 AND OVER; CARBONIC ANHYDRASE INHIBITORS; CLONIDINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAOCULAR PRESSURE; LASER SURGERY; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PROSPECTIVE STUDIES; SULFONAMIDES; THIOPHENES; TIME FACTORS;

EID: 0036820713     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.25.4.237.13484     Document Type: Article

References (31)

1. Steinert RF, Puliafito CA, Kumar SR, Dudak SD, Patel S. Cystoid macular edema, retinal detachment and glaucoma after Nd: YAG laser posterior capsulotomy. Am J Ophthalmol. 1991;112:373-380.
2. Altamirano D, Guex-Crosier Y, Bovey E. Complications de la capsulotomie postérieure au Nd: YAG laser. Etude de 226 cas. Klin Monatsbl Augenheilkd. 1994;204:286-287.
3. Slomovic AR, Parrish RK. Acute elevation of intraocular pressure following Neodymium YAG laser posterior capsulotomy. Ophthalmology. 1985;92:973-975.
4. Jahn CE, Emke M. Long term elevation of intraocular pressure after Neodymium: YAG Laser posterior capsulotomy. Ophthalmologica. 1996;210:85-89.
5. Fourman S, Apisson J. Late onset elevation in intraocular pressure after Neodymiun. YAG laser posterior capsulotomy. Arch Ophthalmol. 1991;109:511-513.
6. Wetzel W. Ocular aqueous dynamics after photodisruptive laser surgery procedures. Ophthalmic Surg. 1994;25:298-302.
7. Altamirano D, Mermoud A, Pittet N. Aqueous humor analysis after Nd: YAG laser posterior capsulotomy with the laser flare cell meter. J Cataract Refract Surg. 1992;18:554-558.
8. Richter CU, Arzeno G, Pappas HR. Prevention of intraocular pressure elevation following Neodymium: YAG laser posterior capsulotomy. Arch Ophthalmol. 1985;103:912-915.
9. Pollack IP, Brown RH, Crandall AS. Prevention of the rise following Neodymium YAG laser posterior capsulotomy using topical 1% ApracIonidine. Arch Ophthalmol. 1988;106:754-757.
10. Brown RH, Stewart RH, Lynch MG, Higgingbotham EJ. ALO 2145 reduces the intraocular pressure elevation after anterior segment laser surgery. Ophthalmology. 1988;95(3):378-384.
11. Robin AL. Short-term effects of unilateral 1% apraclonidine therapy. Arch Ophthalmol. 1988;106:912-915.
12. Coleman AL, Robin AL, Pollack IP. Cardiovascular and intraocular pressure effects and plasma concentrations of apraclonidine. Arch Ophthalmol. 1990;108:1264-1267.
13. Jampel HD, Robin AL, Quigley HA. Apraclonidine: A one-week dose response study. Arch Ophthalmol. 1988;106:1069-1073.
14. Robin AL. Short term effects of unilateral apraclonidine therapy. Arch Ophthalmol. 1988;106:912-915.
15. Wang RF, Serle JB, Pods SM, Sugrue MF. MK 507, a topically active carbonic anhidrase inhibitor, reduces aqueous humor production in monkeys. Arch Ophthalmol. 1991;109:1297-1299.
16. Pfeiffer N. Dorzolamide: Development and clinical application of a topical carbonic anhydrase inhibitor. Survey of Ophthalmology. 1997;42:137-150.
17. Lippa EA, Carlson LE, Yttenborg J. Dose response and duration of action of dorzolamide, a topical carbonic anhidrase inhibitor. Arch Ophthalmol. 1992;110:495-499.
18. Lippa EA, Schuman JS, Wilensky JT. MK 507 versus sezolamide. Ophthalmology. 1991;98(3):308-313.
19. Maus TL, Larsson L, McLaren JW. Comparison of dorzolamide and acetazolamide as supressors of aqueous humor flow in humans. Arch Ophthalmol. 1997;115:45-49.
20. Centofanti M, Manni GL, Napoli D, Bucci MG. Comparative effects on intraocular pressure between systemic and topical carbonic anhydrase inhibitors: A clinical masked, cross-over study. Pharmacological Research. 1997;35:481-484.
21. Rosenberg LF, Krupin T, Tang L. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation. Ophthalmology. 1998;105:88-93.
22. Wilkerson M, Cyrlin M, Lippa EA. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol. 1993;111:1343-1349.
23. Larsson L, Alm A. Aqueous humor flow in human eyes treated with dorzolamide and different doses of acetazolamide. Arch Ophthalmol. 1998;116:19-24.
24. Arieta CEL, Barbosa KB, Rocha EM, Castro RS, José NK. Pilocarpina a 2% na preveção da elevação da pressão intra-ocular pela aplicação de Neodymium YAG Laser em capsulotomia posterior. Arq Bras Oftal. 1993;56:266-268.
25. Brown SL, Thomas JV, Belcher CD, Simmons RJ. Effect of pilocarpine in treatment of intraocular pressure elevation following Neodymium: YAG laser posterior capsulotomy. Ophthalmology. 1985;92:354-359.
26. Silverstone DE, Novack GD, Kelley EP, Chen KS. Prophylactic treatment of intraocular pressure elevations after Neodymium: YAG laser posterior capsulotomies and cataract extractions with levobunolol. Ophthalmology. 1988;95:713-718.
27. Migliori ME, Beckman H, Channel MM. Intraocular pressure changes after Neodymium YAG laser capsulotomy in eyes pretreated with timolol. Arch Ophthalmol. 1987;105:473-475.
28. Loewenstein A, Varssano D, Lazar M, Geyer O. Prevention of the rise in intraocular pressure following Neodymium YAG laser posterior capsulotomy using topical clonidine. Acta Ophthalmologica. 1991;69:462-465.
29. Ladas ID, Pavlopoulos GP, Kokolakis SN, Theodossiadis GP. Prophylactic use of acetazolamide to prevent intraocular pressure elevation following Neodymium YAG laser posterior capsulotomy. Br J of Ophthalmology. 1993;77:136-138.
30. Cullom Jr, RD, Schwartz LW. The effect of apraclonidine on the intraocular pressure of glaucoma patients following Nd: YAG laser posterior capsulotomy. Ophthalmic Surg. 1993;24(9):623-626.
31. Silverstone DE, Brint SF, Burk LL. Prophylactic use of apraclonidine for intraocular pressure increase after Nd: YAG capsulotomies. Am J Ophthalmol. 1992;113:401-105.